BECTON, DICKINSON & CO. (SPARKS) BD PHOENIX NMIC-304; SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT
|
Back to Search Results |
|
Model Number 448486 |
Device Problem
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
Patient Problems
No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/26/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
"multiple lot numbers: there were multiple lot numbers reported to be involved.The information for each lot number is as follows: medical device lot #: 0210495.Medical device expiration date: 2021-08-31.Device manufacture date: 2020-07-28.Medical device lot #: 0245325.Medical device expiration date: 2021-09-30.Device manufacture date: 2020-09-01.Medical device lot #: 0282502.Medical device expiration date: 2021-10-31.Device manufacture date: 2020-10-08.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
|
|
Event Description
|
It was reported that while testing with bd phoenix¿ nmic-304 there was false resistance.
|
|
Event Description
|
It was reported that while testing with bd phoenix¿ nmic-304 there was false resistance.
|
|
Manufacturer Narrative
|
This complaint is for false resistant carbapenem results when using phoenix panel nmic 304 (448486) batches 0210495, 0245325 and 0282502.The customer provided lab report results, binary files and isolate returns for investigation.Five retention panels from a separate batch of this panel type nmic 304 (448486) were used to test each of the five isolates provided by the customer.Ertapenem (etp) was tested with escherichia coli 1598m.Imipenem (ipm) was tested with escherichia coli 0168m.Imipenem (ipm) was tested with escherichia coli 108m.Ertapenem (etp) was tested with proteus mirabilis 2348m.Ertapenem (etp) was tested with escherichia coli 0013m.The five panels yielded sensitive results per the package insert.Two retention panels from complaint batch 0282502 were used to test ertapenem (etp) using clinical isolate escherichia coli 1598m, where both yielded sensitive results per the package insert.Two retention panels from complaint batch 0245325 were used to test ertapenem (etp) using clinical isolate escherichia coli 0013m, where both yielded sensitive results per the package insert.Eight retention panels from complaint batch 0210495 were used.Imipenem (ipm) was tested with escherichia coli 0168m.Imipenem (ipm) was tested with escherichia coli 108m.Ertapenem (etp) was tested with proteus mirabilis 2348m.Ertapenem (etp) was tested with escherichia coli 0013m.All panels yielded sensitive results per the package insert.This complaint is not confirmed.A review of quality notifications revealed no quality notifications generated on any of the three complaint batches.A review of complaints revealed no complaints generated on any of the three complaint batches.Complaint trending was performed and no trends were identified for this defect.Bd id/ast plant quality will continue to monitor for trends associated with this defect and take action as necessary.
|
|
Search Alerts/Recalls
|
|
|